Abstract
Introduction: Patients with head and neck squamous cell carcinoma (HNSCC) are at risk for long-term side effects and require thorough survivorship care following completion of radiation therapy (RT). We aimed to identify survivorship interest and needs following RT. Methods: Patients with HNSCC who completed RT from Jan 2013 to April 2023 completed questions based on the five-domain Cancer Survivorship Framework (physical effects, psychosocial effects, cancer screening, chronic conditions, health promotion) and the Consolidated Framework for Implementation Research (interest, knowledge, barriers). Results: Of 1,123 patients, 317 participated (response rate 28%). Patients were 64% (n = 203) male with a mean age of 64 years (SD 12), with 66% (n = 209) finishing treatment > 2-years prior. 36% (n = 115) were interested in, 34% (n = 108) prioritized, and 28% (n = 88) had information related to survivorship. For survivorship domains, within physical effects, dry mouth (40%, n = 126) and trouble swallowing (24%, n = 75) were most bothersome. For psychosocial, 15% (n = 46) reported current depression (mean PHQ2 score ≥ 3) and 71% (n = 226) felt mental health needs were not addressed during treatment. Forty-two percent felt that diet, exercise, and smoking were not addressed (n = 134). Seventy-six percent (n = 240) understood the importance of cancer screening. Most patients wished to address survivorship topics in one long visit (45%, n = 142) and preferred in-person visits (60%, n = 190). Potential barriers included insurance coverage and scheduling concerns. Conclusion: In post-RT HNSCC survivors, survivorship interest and knowledge were limited. There is a need for education on survivorship. Implications: These findings provide a foundation for developing robust survivorship care programs that meet the diverse needs of this patient population.
Original language | English (US) |
---|---|
Article number | 403 |
Journal | Supportive Care in Cancer |
Volume | 33 |
Issue number | 5 |
DOIs | |
State | Published - May 2025 |
Funding
REDCap is supported by the Northwestern University Clinical and Translational Science (NUCATS) Institute. Research reported in this publication was supported, in part, by the National Institutes of Health\u2019s National Center for Advancing Translational Sciences, Grant Number UL1 TR001422.
Keywords
- Head and neck cancer
- Radiotherapy
- Survivorship
ASJC Scopus subject areas
- Oncology